Alector (ALEC) Non-Current Debt (2024 - 2026)
Alector's (ALEC) quarterly Non-Current Debt came in at $8.3 million in Q1 2026, down 12.44% year-over-year from $9.5 million in Q1 2025, and down 11.11% quarter-over-quarter from $9.3 million in Q4 2025.
Analysis
Alector (ALEC) Non-Current Debt (2024 - 2026) Analysis & Trends
Alector (ALEC) has reported Non-Current Debt for 3 consecutive years, with $8.3 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Non-Current Debt fell 12.44% year-over-year to $8.3 million in Q1 2026; TTM through Mar 2026 was $8.3 million, a 12.44% decrease from a year earlier, with the FY2025 full-year figure at $9.3 million, down 0.7% from the prior year.
- Non-Current Debt was $8.3 million for Q1 2026 at Alector, down from $9.3 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $9.6 million in Q3 2025 and troughed at $8.3 million in Q1 2026.
- A 3-year average of $9.3 million and a median of $9.4 million in 2024 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt slipped 0.7% in 2025 and slipped 12.44% in 2026, its largest moves.
- Over 3 years, Non-Current Debt stood at $9.4 million in 2024, then declined by 0.7% to $9.3 million in 2025, then fell by 11.11% to $8.3 million in 2026.
- The last three Non-Current Debt figures came in at $8.3 million (Q1 2026), $9.3 million (Q4 2025), and $9.6 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 57.30 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 26.25 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 1.99 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 591.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 7.29 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 8.29 Mn |
| Dec 31, 2025 | 9.32 Mn |
| Sep 30, 2025 | 9.61 Mn |
| Jun 30, 2025 | 9.54 Mn |
| Mar 31, 2025 | 9.46 Mn |
| Dec 31, 2024 | 9.39 Mn |